Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
PCR Biosystems
PCR Biosystems
Activities:
Ingredients
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
PCR Biosystems launches new family of qPCR reagent mixes
In research laboratories, qPCR assays are used for a diverse range of applications
Ingredients
PCR Biosystems launches lyophilisable reagent mix
Lyophilised test formats may help circumvent transport and storage challenges
Ingredients
Bst Polymerase reagents for accelerated DNA amplification
PCR Biosystems’ range has been validated for qualitative detection of the SARS-CoV-2 nucleic acid
Research & Development
PCR Biosystems introduces quantification kit for Illumina
NGSBIO Library Quant kit enables quantification across a range of sample types, concentrations, fragment sizes and GC content
Analysis
PCR Biosystems launches standalone RNase Inhibitor
While it has previously been a component of several PCR Biosystems kits, the RNase inhibitor is now available as a standalone product
Ingredients
PCR Biosystems scales up COVID-19 testing enzyme production
UK-based PCR Biosystems has introduced bulk pack sizes of this key product, to further support customers in high-throughput COVID-19 testing
Subscribe now